COVID-19 Impact on Global Meropenem Injection Market

  • The U.S. accounted for major share of the meropenem injection market in North America in 2020, as antibiotics prescription rate is the highest in the country. The U.S. is one of the countries directly affected by the COVID-19 outbreak. This has led to rise in demand for antibiotics in the U.S.
  • Meropenem is used to treat pneumonia in combination with vancomycin, which is driving demand.

Global Meropenem Injection Market: Key Trends

  • The global meropenem injection market is projected to expand at significant growth rate during forecasting period from 2021 to 2028
  • Demand for global meropenem injection is increasing due to rise in prevalence of infectious diseases. High prevalence of infectious diseases such as stomach infections, lower respiratory infections, pneumonia, malaria, and tuberculosis fuels the growth of the global market. Surge in disease burden is compelling governments and non-governmental organizations to invest in R&D and accelerate the development of novel antibiotics and formulate supportive regulatory policies to expedite the approval process and research funding.
  • Increase in efforts of pharmaceutical companies for the development of novel therapies to treat infectious diseases is expected to drive the global market during the forecast period
  • Meropenem injection, USP, is used to treat streptococci, E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, and Peptostreptococcus species as a single agent therapy. This is likely to propel the global meropenem injection market in the next few years.
  • Imipenem and meropenem were discovered by scientists at the University of South Australia. The two drugs are the most powerful antibiotics used in medicine. This is projected to boost the growth of the global market during the forecast period.
  • Demand for meropenem injection is driven by rise in prevalence of bacterial infections and increase in need of more effective and newer antibiotics. According to the World Health Organization (WHO), 10 million people globally were infected with tuberculosis in 2019, and 1.4 million people succumbed to the disease. Additionally, infectious diseases are emerging as a result of urbanization, destruction of natural habitats, and climate change and changing ecosystems. This puts a significant strain on developing economies.

North America to Capture Major Share of Meropenem Injection Market

  • North America was the largest market for meropenem injection in 2020 due to high expenditure on meropenem injection in the region. Product utilization is increasing owing to rise in population and buyers.
  • The market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to rise in prevalence of skin and abdominal infections caused by bacteria and meningitis

Key Players Operating in Global Meropenem Injection Market:

Major players operating in the global meropenem injection market are listed below:

  • Pfizer
  • WG Critical Care
  • Sagent
  • AuroMedics
  • Fresenius Kabi
  • Sandoz
  • PKU HealthCare
  • B. Braun
  • Amneal
  • Xinya Pharm
  • United Laboratories
  • CSPC Group
  • Luoxin Group

Global Meropenem Injection Market: Research Scope

Global Meropenem Injection Market, by Type

  • 0.5g/50ml
  • 1g/50ml

Global Meropenem Injection Market, by Application

  • Hospitals
  • Clinics
  • Recovery Centers

Global Meropenem Injection Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Meropenem Injection Market: Introduction

  • Meropenem is a carbapenem antibiotic with a broad spectrum of activity. It has antibacterial properties against both Gram-positive and Gram-negative bacteria. It is used to treat severe skin and stomach infections. Meropenem is also used in the treatment of bacterial meningitis (infection that causes inflammation of the tissue that covers the brain and spinal cord).

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Meropenem Injection Market